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SUMMARY 
The insulin-releasing ability and uptake characteristics of non-metabolizable, 
transport-specific amino acids were studied in an in vitro system, using microdissected 
pancreatic islets with more than 9 ° O//o/~-cells. 
Among the four stereoisomers of 2-aminobicyclo(2,2,i)heptane-2-carboxylic 
acid (BCH), only the b(-- )  form stimulated insulin release. This isomer is known as a 
specific substrate for transport  system L in other cells. I t  was rapidly taken up by the 
islet cells and stimulated insulin release both in the presence and in the absence of 
glucose. 
4-Amino-I-guanylpiperidine-4-carboxylic acid (GPA), a substrate for cationic 
transport  systems, stimulated insulin release in the presence but not in the absence 
of glucose. In this respect GPA is similar to arginine. Like arginine, GPA also accu- 
mulated in the islet cells to yield distribution ratios well above unity. 
The results are consonant with the previous hypothesis that  amino acids 
stimulate insulin release by binding to specific transport  molecules. 
INTRODUCTION 
The use of non-metabolizable model amino acids has been instrumental to the 
discrimination of specific transport  systems in various cells 1. For example, ~-amino- 
isobutyrie acid was developed as a model substrate for transport  System A, 2-amino- 
bicyclo(2,2,i)heptane-2-carboxylic acid (BCH) as a leucine analogue with specificity 
for System L, and 4-amino-I-guanylpiperidine-4-carboxylic acid (GPA) as a model 
substrate for the system for cationic amino acids. The first of these was observed 
under certain conditions to stimulate the release of insulin from cultivated fetal 
pancreas (A. E. RENOLD et al., personal communication to H. N. CHRISTENSEN, 1968 ) ; 
the second substance was concurrently found to exert a hypoglycemic action 2,5 and 
to elevate the level of immunologically reactive insulin1, ~ in the intact rat. Subse- 
quently, the amino acid was shown to behave as a functional analogue of leucine in 
stimulating the rise of the plasma insulin level in the dog 3. More recently, GPA has 
been shown to stimulate increase of the plasma levels of both insulin and glucagon 
in the rat  1 and the dog (S. S. FAJANS, H. S.  CHRISTENSEN et al., unpublished work). 
Abbreviat ions:  BCH, 2-aminobicyclo(2,2,I)heptane-2-carboxylic acid; GPA, 4-amino- 
i-guanylpiperidine-4-carboxylic acid. 
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Several natural amino acids, including leucine, are known to stimulate the in vitro 
release of insulin. I t  seemed therefore reasonable to attr ibute the effects of BCH to 
a direct action on the pancreatic/3-cells. Since, furthermore, these model amino acids 
were designed as transport-specific substrates, insulin release was suggested to be 
triggered by  the binding of amino acids to their specific transport  molecules in the 
fl-cell membrane 2. 
In the present paper, we test this hypothesis by studying the insulin-releasing 
potency of different BCH stereoisomers and of GPA in vitro. In addition, it was checked 
whether the pancreatic fl-cells are able to transport  these model substrates. To 
obtain results representative of the //-cells, islets were microdissected from obese- 
hyperglycemic mice. These islets contain more than 9 ° % fl-cells, which are known to 
respond adequately to all secretagogues tested including natural amino acids such as 
leucine and arginine. 
MATERIALS AND METHODS 
Chemicals 
The synthesis, 1~C labelling and resolution of BCH were done as previously 
described a, 5. Synthesis and 1~C labelling of GPA will be described elsewhere by one 
of us (H.N.C.). EI-3HlMannitol and E6,6'-3H21sucrose were obtained from the Radio- 
chemical Centre, Amersham, England. Crystalline mouse insulin was prepared by 
Novo Industri  A/S, Copenhagen, Denmark. All other chemicals were commercially 
available reagents of analytical grade. Distilled and de-ionized water was used 
throughout.  
Isolation of islets 
Adult obese-hyperglycemic mice (gene symbol: obob) from the Ume£ colony 
were starved overnight. Fresh pancreatic islets were isolated by free-hand micro- 
dissection 6 in Krebs-Ringer  buffer including 0.3-0.5 % (w/v) human serum albumin 
and equilibrated with 02-C02 (95:5, v/v). 
Incubations 
All incubations were performed at 37 °, using Krebs-Ringer buffer as basal 
medium. In studies of insulin release, incubation was first performed for 4 ° min. 
Batches of 2 islets were then incubated in I15 #1 medium for a short initial period of 
5 rain (early phase) followed by incubation for 60 min (late phase) in 315/,1 medium. 
The amounts of insulin released were measured in samples of medium taken from the 
three incubation periods, allowing correction for insulin present in a minimum volume 
left from the preceding incubation period. Details of experiments are given in the 
legends to figures and tables. 
In studies of amino acid uptake, islets were first incubated in basal medium. 
Batches of IO islets were subsequently incubated with radioactive amino acid. In 
some experiments the medium also contained Ei-3Hlmannitol or [6,6'-aH2]sucrose, 
which made it possible to correct for contaminating label and label in the extracellular 
space (B, HELLMAN, J. SEHLIN AND I.-B. T-KLJEDAL, unpublished work). When extra- 
cellular markers were not used, the incubated islets were washed for 4 × i rain in 
ice-cold, non-radioactive medium v. The detailed composition of incubation media as 
well as the length of incubation times are given in the legends to figures and tables. 
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Insulin assay 
Insulin was assayed with the double-antibody method 8, using crystalline mouse 
insulin as standard. 
Determination of amino acid uptake 
After weighing (see below), the incubated islets were dissolved by incubation at 
room temperature in IOO #I of hyamine for 45 min. After addition of IO ml scintillation 
liquid (5 g of 2,5-diphenyloxazole and 5 ° mg 1,4-bis-2-(5-phenyl-oxazolyl)benzene in 
I 1 of toluene), counting was carried out in a liquid scintillation spectrometer. The 
observed counts/min values were translated to mmoles of labelled substrate by  com- 
parison with external standards counted in parallel with the islets. These standards 
consisted of 5 #1 incubation medium dissolved in ioo/~1 of hyamine. In double-label 
experiments the setting of the discriminators was such that  less than 0.5 % of the 
3H counts were also counted in the 14C channel. Spill-over to the 3H channel was 25 % 
of the counts in the 14C channel. The specific radioactivities were chosen to give 
approximately the same counts/min in either channel. 
Weighing of islets 
Incubated islets were placed on bits of aluminium foil and were gently freed 
of as much contaminating fluid as possible with the aid of a micropipette. After 
freeze-drying (--4 o°, o.ooi m m  Hg) overnight, the islets were weighed on a quartz- 
fibre balance 9. 
RESULTS 
Experiments with BCH 
As shown in Table I, a racemic mixture of b (+ ) -BCH and b( --)-BCH stimulated 
insulin release, whereas a mixture of a (+ ) -BCH and a ( - ) - B C H  did not. The effect 
of b (+ ) -BCH was obtained both in the absence and in the presence of glucose. 
T A B L E  I 
EFFECTS OF a ( ± ) - B C H  AND b ( ± ) - B C H  ON INSULIN RELEASE 
A m o u n t s  of insu l in  re leased dur ing  6o m in  of i n c u b a t i o n  are  g iven  as m e a n  va lues  -4- S.E. for 
the  number s  of e x p e r i m e n t s  i nd i ca t ed  w i t h i n  pa ren theses .  I n  each e x p e r i m e n t  is le ts  f rom a s ingle  
a n i m a l  were i n c u b a t e d  w i t h  5 or i o  mM BCH  as wel l  as in a ]3CH-free con t ro l  med i um.  A s t a t i s t i c a l  
t e s t  of the  m e a n  differences be tween  t e s t  and  cont ro l  med ia  revea led  t h a t  b( :~)-]3CH h a d  a 
s ign i f ican t  effect b o t h  in the  absence  (5 raM: P < o.o5; i o  raM: P < o.ooi)  and  in  the  presence  
( io  mM: P < 0.02) of glucose. 
Glucose conen, ng insulin released per i~g dry islet 
(raM) 
o m M  amino acid 5 m M  amino acid io  m M  amino acid 
Experiments with b( ± ) - B C H  
o 0-36 ± 0.07 (9) i . o i  ± o.25 (9) 
IO 8.09 ~ 1.12 (9) IO.II  ± 1.55 (9) 
Experiments with a( ± ) - B C H  
o 0.55 -+- o.2o (8) 0.56 :~ o.16 (8) 
IO 4.38 ± o.51 (8) 4.o3 ! 0.38 (8) 
1.92 ± o.I8  (9) 
12.75 ~ 1.43 (9) 
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Table I I  shows the effects of isolated b ( - ) - B C H  and b (+) -BCH isomers. 
Whereas b (+ ) -BCH failed to stimulate insulin release, significant effects were obtained 
both in 5-rain and 6o-min incubations with b ( - ) - B C H .  The effects of b( - ) - B C H  did 
not require the presence of glucose. The relationship between the b ( - ) - B C H  con- 
centration and the rate of insulin release is given in Fig. i. The dose-response relation- 
ship was apparently hyperbolic with maximum stimulation at about 20 mM and an 
apparent  Km of around 7 mM. 
TABLE I I  
E F F E C T S  O F  b ( + ) - B C H  A N D  b( )-BCH O N  I N S U L I N  R E L E A S E  
Amount s  of insulin released during the first 5 min (early phase) or subsequent  60 min (late phase) 
af ter  exposure  to BCH are given as mean values -4- S.E. for the numbers  of exper iments  indicated 
within parentheses .  In  each exper iment  islets from a single animal  were incubated with 5 mM 
b( + )-BCH or b( - - ) -BCH as well as in a BCH-free medium. A statist ical tes t  of the mean differences 
between tes t  and control  media revealed t ha t  b ( - - ) -BCH had a significant effect bo th  in the 
absence (early phase:  P < 0.02; late phase:  P < 0.025) and presence (late phase:  P < 0.05) of 
glucose. 
Glucose conch, ng insulin released per i~g dry islet 
(raM) 
Control 5 m2"VI b( + )-BCH 5 m M  b(--)-BCH 
Early phase 
o o.I2 ± 0.03 (9) o.19 ± 0.06 (IO) 0.37 i 0.08 ( I O )  
IO o.82 ~ o. I I  (IO) 0.63 ~ o.13 (IO) 0.80 ± o.17 (IO) 
17 0.88 ± o.I 7 (IO) 
Late phase 
o 0.33 4- 0.06 (IO) 0.36 ± 0.08 (IO) I.OO ~ 0.34 (IO) 
IO 6.05 ± 0.83 (IO) 5.94 -c 0.52 (IO) 8.24 =c 0.87 (IO) 
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Fig. i. Concentra t ion-dependency of insulin release in response to b ( - - ) -BCH during 6o miu of 
incubation.  Mean values -t= S.E. for 9-1o different experiments .  
Fig. 2. Is let  up take  of b ( + ) - B C H  (O) and b( )-BCH (O) with time. After incubat ion  for 3o min 
in glucose-free KRB,  islets were incubated for different periods of t ime in media containing 
i .o mM [carboxyl-14C]-b(+)-BCH or [carboxyl-a4C]-b(--)-BCH (i.o mC/mmole),  as well as o. I mM 
[ i -~H]manni tol  (25.0 mC/mmole).  The am oun t s  of BCH taken up by the islet cells were calculated 
by  correction for label in the manni to l  space. Mean values ± S.E. for 4-13 observat ions.  
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Islet uptake of b(+)-BCH and b ( - ) - B C H  was studied in double-label experi- 
ments using [I-SH]mannitol as extracellular marker. As shown in Fig. 2, the islet 
content of either isomer rapidly exceeded that  of mannitol, which suggests that  both 
b(+)-BCH and b ( - ) - B C H  were rapidly taken up by the fl-cells. A statistical analysis 
of the results indicates that  the level of b(+)-BCH was probably higher than that  of 
b ( - ) - B C H  after 45 rain of incubation (P < 0.05). 
Experiments with GPA 
The effect of GPA on insulin release is presented in Table III. When tested at a 
concentration of 5 mM, the arginine analogue failed to enhance insulin release. A 
probably significant stimulation was, however, noted after 60 rain of incubation with 
IO mM GPA in the presence of IO mM glucose. 
TABLE I I I  
EFFECT OF GPA ON INSULIN RELEASE 
Resul ts  are presented as in Table II .  The effect of io mM GPA in the presence of io mM glucose 
was  probably  significant (P<o .o5)  during the late phase. 
Glucose cohen, ng insulin released per I~g dry islet 
(raM) 
Control 5 m M  GPA Io m M  GPA 
Early phase 
o o.I5 + 0.05 (8) o.21 + 0.05 (7) o.i8 4- 0.08 (8) 
io 0.88 4- 0.24 (8) 1.o7 i 0-47 (7) o.91 _ o.17 (9) 
Late phase 
o 0.34 4- 0.08 (9) 0-50 i o.18 (8) 0.48 4- o.16 (8) 
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Fig. 3. Is let  up take  of C-PA with  time. After incubat ion  for 3 ° min in glucose-free KRB,  islets 
were incubated for different periods of t ime in media containing 2.0 mM [carboxyl-14C]GPA 
(0. 3 mC/mmole).  In  one series of exper iments  (O) the media also contained o.i mM (6,6'-3H=] - 
sucrose (2o.o mC/mmole)  as extracellular  marker .  The a m o u n t s  of GPA taken up  by  the islet cells 
were in these exper iments  calculated by correct ion for label in the sucrose space. In  ano the r  
series of exper iments  ( 0 )  con tamina t ing  and extracellular label was removed by  washing after  
incubation.  Each poin t  represents  the mean  of 2 ( 0 )  or  3 (O) different experiments .  In  addition,  
the range of observat ions  in double-label exper iments  are given. 
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Fig. 3 shows that  the islet cells were able to accumulate GPA to yield distribu- 
tion ratios much higher than unity. I t  should be noted that  identical results were 
obtained irrespective of whether washing or double-labelling was used to correct for 
extracellular and contaminating radioactivity. 
DISCUSSION 
Several amino acids are able to stimulate insulin release 1°. Most of these, 
including arginine, do so in the presence of glucose, whereas leucine acts as a secreta- 
gogue also in glucose-free media n. The in vivo action of BCH resembles that  of leucine 
and contrasts with that  of arginine in persisting when mannoheptulose has been 
infused 3. I ts  hypoglycemic action was found to be limited to the b ( - ) - i somer  of 
BCH',  5,1~. The mechanism by which amino acids stimulate insulin release is not clear. 
The action of BCH in vivo indicates that  the secretory response of the fl-cells does not 
require metabolism of the amino acid1, 2 (cf. ref. IO). As an alternative hypothesis, 
CHRISTENSEN AND CULLEN 2 suggested that  insulin release is triggered by the binding 
of amino acids to specific transport  molecules in the fl-cell membrane. 
The present in vitro study was undertaken to elucidate the following problems 
that  arise as a consequence of the above hypothesis. (I) Is BCH-induced hypo- 
glycemia due to a pr imary effect on the fl-cells? (2) Are the fl-cells stimulated by other 
transport-specific amino acids? (3) Is there a difference in insulin-releasing activity 
between the four stereo-isomers of BCH? (4) Is there a correlation between the insulin- 
releasing activity of different BCH isomers and their uptake characteristics? 
A direct effect of BCH on fetal rat  pancreas has recently been described 13. 
This pancreas preparation differs, however, from adult islets in its sensitivity to 
various amino acids. For example, islets of obese-hyperglycemic mice are not stimulat- 
ed by alanine or a-aminoisobutyric acid (A. Lernmark, unpublished work), whereas 
these amino acids are potent secretagogues with the fetal rat  pancreas preparation la, 1~. 
Amino acids, not including BCH or leucine a, are also known to stimulate the release of 
glucagonl0,15, which is in turn an insulin secretagogue. In the present s tudy advantage 
was taken of the unusually low proportion of s-cells in the microdissected islets of 
obese-hyperglycemic mice 1~. Our results are therefore most probably representative 
for the fi-cells and support the idea that  BCH exerts a direct st imulatory action on 
these cells. 
If the hypothesis of CHRISTENSEN AND CULLEN 2 is correct, one would expect 
a transport-specific arginine analogue to mimick arginine also as an insulin secreta- 
gogue. Circumstantial evidence that  this is the case has been obtained by measuring 
plasma insulin in GPA-injected rats ~ and dogs (S. S. FAJANS, H. N. CHRISTENSEN 
et al., unpublished work). From the present results it is clear that  GPA is taken up by 
the islet cells and that  it stimulates insulin release in vitro. The glucose dependency of 
GPA as an insulin secretagogue contrasts with the glucose independency of b ( - ) -  
BCH and supports the idea that  GPA acts by the same mechanism as arginine. Tile 
fact that  glucose also potentiates the effect of glucagon on insulin release 17 stresses 
the question whether the effect of GPA might be fully explained by its action as a 
glucagon secretagogue 1. This possibility seems most unlikely, however, in view of the 
very low proportion of a-cells in the present islets TM. 
A racemic mixture of b (+ ) -BCH and b( --)-BCH stimulated insulin release signi- 
ficantly, whereas a similar mixture of a (+ ) -BCH and a(- - ) -BCH was without effect. 
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I t  seems therefore unlikely that  the a(+)-isomers contribute to the hypoglycemic 
action of BCH. After resolution of the individual b-isomers, it was evident tha t  only 
b(- - ) -BCH was effective as a stimulus of insulin release. With the latter isomer there 
was a significant enhancement of insulin release both in the absence and in the presence 
of glucose. In this respect, the behaviour of b( - ) - B C H  is strikingly similar to leucine. 
The structure of BCH was originally designed to provide a sufficiently bulky 
"side-chain" to keep it out of transport  systems other than L. An incidental conse- 
quence of its structure is that  the molecule not only escapes degradation but is subject 
to rather  little distortion. The recognition site for insulin release obviously finds these 
characteristics no significant handicap and responds almost as though BCH were 
leucine; hence we are led to say that  this recognition site resembles a transport  site 
in not requiring that  the "subst ra te"  be either destabilized or distorted. I t  also re- 
sembles a transport  site in finding only one of the four possible dispositions of the 
sidechain mass of BCH suitable to a response, namely that  shown by the isomer b ( - ) .  
This isomer is the only one tha t  shows measurable uptake by Escherichia coli, utilizing 
a transport  system serving for leucine, isoleucine and valine 1. The same isomer tends 
to have the most rapid uptake by  various cells and tissues, and only it is regarded as 
a fully characteristic substrate of the so-called L system. Nevertheless, b ( + )  and b ( - )  
were taken up about equally rapidly by  the isolated islets. In certain other tissues 
the a(+)- isomer  has been shown in the Michigan laboratory to be transported ap- 
proximately as well as the b( - ) - i somer .  We may  of course question whether the same 
receptor site is involved for the two isomers in the two cases. 
Because not much is known of recognition sites other than transport  sites that  
need not degrade and perhaps not even to distort the substrate, it has been tempting 
to conclude that  the site signalling insulin release is a t ransport  receptor site, or is 
evolved from a transport  receptor site s. This proposal did not specify which conse- 
quence of entry of a solute into a t ransport  site might produce the signal, but presum- 
ably the response of the site, perhaps an induced fit to the substrate or a modification 
of conformational relations among participating macromolecules, is necessary to a 
signal. The circumstance that  we now have uncovered an arginine-like insulin re- 
leasing agent in the first model substrate constructed for the transport  system for 
cationic amino acids, and that  this substrate is transported vigorously into the islet, 
encourages the same viewpoint. In the absence of a perfect correspondence between 
the amino acids that  are transported and those that  stimulate insulin release, how- 
ever, only detailed analysis of the effector system can establish the hypothesis. For 
the present its main merit may  be to provide us with a provisional example of the 
kind of recognition site needed to explain the signalling for insulin release. 
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